A stem cells' metabolome
By using a metabolomic approach, a group of researchers have described some key differences between stem cells and mature cells as well as metabolites associated with the transition between the two.
As stem cells mature they change to form all the different cells that our bodies use. Control of this process could give doctors the tools to meet the needs of many patients with terrible conditions, such as Parkinson’s disease and spinal injuries. By using a metabolomic approach, a group of researchers have described some key differences between stem cells and mature cells as well as metabolites associated with the transition between the two.
Published in the on-line edition of Nature Chemical Biology,1 the study used LC–MS to analyse the stem cells’ metabolome and found 60 previously unidentified metabolites associated with the cell progression. “The study reveals an astounding cellular strategy,” commented Oscar Yanes, one of the researchers. “The capacity of embryonic stem cells to generate a whole spectrum of cell types characteristic of different tissues is mirrored at the metabolic level.”
The team suggests that the stem cells’ metabolome allows them to react to in vivo oxidative processes such as inflammation. Supporting this theory, the researchers found that by chemically blocking the oxidative processes, they were able to prevent stem cells’ normal progress into mature heart and nerve cells. Conversely, when specific oxidized metabolites were introduced downstream into the culture, stem cell differentiation was promoted.
1O. Yanes, Nature Chemical Biology, on-line 2 May 2010.
This story originally appeared in The Column. Click here to view that issue.
An LC–HRMS Method for Separation and Identification of Hemoglobin Variant Subunits
March 6th 2025Researchers from Stanford University’s School of Medicine and Stanford Health Care report the development of a liquid chromatography high-resolution mass spectrometry (LC–HRMS) method for identifying hemoglobin (Hb) variants. The method can effectively separate several pairs of normal and variant Hb subunits with mass shifts of less than 1 Da and accurately identify them in intact-protein and top-down analyses.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
